Nifty
Sensex
:
:
25149.85
82500.47
-205.40 (-0.81%)
-689.81 (-0.83%)

Pharmaceuticals & Drugs - API

Rating :
N/A

BSE: 532488 | NSE: DIVISLAB

6835.00
11-Jul-2025
  • Open
  • High
  • Low
  • Previous Close
  •  6830
  •  6905.5
  •  6825
  •  6844.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  224031
  •  1537027484.5
  •  7071.5
  •  4395.3

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,81,397.34
  • 82.79
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,77,703.34
  • 0.44%
  • 12.12

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.89%
  • 1.24%
  • 7.17%
  • FII
  • DII
  • Others
  • 18.01%
  • 20.15%
  • 1.54%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.68
  • 7.78
  • -4.33

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.58
  • 3.89
  • -10.68

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.51
  • 3.05
  • -18.54

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 48.35
  • 57.40
  • 70.92

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.47
  • 9.78
  • 8.65

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 32.65
  • 37.88
  • 38.97

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
60.27
82.53
101.82
126.14
P/E Ratio
17.46
12.75
10.33
8.34
Revenue
7796
9360
10987
12965
EBITDA
2205
2968
3690
4572
Net Income
1600
2191
2692
3335
ROA
10.7
13.5
15.4
16.6
P/B Ratio
2.07
1.87
1.67
1.47
ROE
12.15
15.35
16.87
18.42
FCFF
556
508
900
1420
FCFF Yield
0.32
0.29
0.52
0.82
Net Debt
-3977
-3711
-4131
-4790
BVPS
507.93
563.87
628.85
717.03

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
2,585.00
2,303.00
12.24%
2,319.00
1,855.00
25.01%
2,338.00
1,909.00
22.47%
2,118.00
1,778.00
19.12%
Expenses
1,699.00
1,572.00
8.08%
1,576.00
1,366.00
15.37%
1,622.00
1,430.00
13.43%
1,496.00
1,274.00
17.43%
EBITDA
886.00
731.00
21.20%
743.00
489.00
51.94%
716.00
479.00
49.48%
622.00
504.00
23.41%
EBIDTM
34.27%
31.74%
32.04%
26.36%
30.62%
25.09%
29.37%
28.35%
Other Income
86.00
79.00
8.86%
82.00
95.00
-13.68%
106.00
86.00
23.26%
79.00
81.00
-2.47%
Interest
1.00
2.00
-50.00%
0.00
0.00
0
1.00
1.00
0.00%
0.00
0.00
0
Depreciation
107.00
95.00
12.63%
99.00
95.00
4.21%
99.00
95.00
4.21%
97.00
93.00
4.30%
PBT
864.00
713.00
21.18%
726.00
489.00
48.47%
722.00
469.00
53.94%
604.00
492.00
22.76%
Tax
202.00
175.00
15.43%
137.00
131.00
4.58%
212.00
121.00
75.21%
174.00
136.00
27.94%
PAT
662.00
538.00
23.05%
589.00
358.00
64.53%
510.00
348.00
46.55%
430.00
356.00
20.79%
PATM
25.61%
23.36%
25.40%
19.30%
21.81%
18.23%
20.30%
20.02%
EPS
24.98
20.30
23.05%
22.23
13.51
64.54%
19.25
13.13
46.61%
16.23
13.43
20.85%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
9,360.00
7,845.00
7,767.00
8,959.83
6,969.40
5,394.42
4,946.26
3,891.49
4,064.34
3,776.36
3,114.94
Net Sales Growth
19.31%
1.00%
-13.31%
28.56%
29.20%
9.06%
27.10%
-4.25%
7.63%
21.23%
 
Cost Of Goods Sold
3,725.00
3,129.00
3,053.00
2,967.14
2,324.08
2,108.54
1,825.22
1,534.06
1,534.00
1,505.32
1,213.24
Gross Profit
5,635.00
4,716.00
4,714.00
5,992.69
4,645.32
3,285.88
3,121.04
2,357.43
2,530.34
2,271.04
1,901.70
GP Margin
60.20%
60.11%
60.69%
66.88%
66.65%
60.91%
63.10%
60.58%
62.26%
60.14%
61.05%
Total Expenditure
6,393.00
5,639.00
5,398.00
5,078.72
4,108.34
3,571.21
3,073.24
2,628.74
2,617.20
2,358.04
1,948.69
Power & Fuel Cost
-
477.00
496.00
392.33
319.15
280.73
248.78
228.73
198.80
180.34
170.82
% Of Sales
-
6.08%
6.39%
4.38%
4.58%
5.20%
5.03%
5.88%
4.89%
4.78%
5.48%
Employee Cost
-
1,094.00
975.00
946.16
825.76
621.05
542.27
456.06
499.90
361.19
290.42
% Of Sales
-
13.95%
12.55%
10.56%
11.85%
11.51%
10.96%
11.72%
12.30%
9.56%
9.32%
Manufacturing Exp.
-
425.00
401.00
365.92
297.84
258.91
212.96
182.67
169.15
169.42
147.24
% Of Sales
-
5.42%
5.16%
4.08%
4.27%
4.80%
4.31%
4.69%
4.16%
4.49%
4.73%
General & Admin Exp.
-
283.00
304.00
236.44
175.26
148.62
105.30
139.33
88.22
73.91
63.85
% Of Sales
-
3.61%
3.91%
2.64%
2.51%
2.76%
2.13%
3.58%
2.17%
1.96%
2.05%
Selling & Distn. Exp.
-
90.00
114.00
127.01
124.03
85.36
73.08
64.02
67.48
56.04
51.93
% Of Sales
-
1.15%
1.47%
1.42%
1.78%
1.58%
1.48%
1.65%
1.66%
1.48%
1.67%
Miscellaneous Exp.
-
141.00
55.00
43.72
42.22
68.00
65.63
23.87
59.65
11.80
51.93
% Of Sales
-
1.80%
0.71%
0.49%
0.61%
1.26%
1.33%
0.61%
1.47%
0.31%
0.36%
EBITDA
2,967.00
2,206.00
2,369.00
3,881.11
2,861.06
1,823.21
1,873.02
1,262.75
1,447.14
1,418.32
1,166.25
EBITDA Margin
31.70%
28.12%
30.50%
43.32%
41.05%
33.80%
37.87%
32.45%
35.61%
37.56%
37.44%
Other Income
353.00
339.00
345.00
115.90
62.67
189.63
155.63
113.44
74.89
97.44
44.70
Interest
2.00
4.00
2.00
2.00
2.10
7.14
4.68
2.37
3.36
4.74
2.88
Depreciation
402.00
378.00
343.00
311.51
255.59
186.24
168.90
142.49
123.33
118.18
136.00
PBT
2,916.00
2,163.00
2,369.00
3,683.50
2,666.04
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
Tax
725.00
563.00
545.00
723.05
681.75
442.92
502.33
354.32
334.92
267.06
220.56
Tax Rate
24.86%
26.03%
23.01%
19.63%
25.57%
24.34%
27.08%
28.78%
24.00%
19.17%
20.57%
PAT
2,191.00
1,600.00
1,824.00
2,960.45
1,984.29
1,376.54
1,352.74
877.01
1,060.42
1,125.78
851.52
PAT before Minority Interest
2,191.00
1,600.00
1,824.00
2,960.45
1,984.29
1,376.54
1,352.74
877.01
1,060.42
1,125.78
851.52
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
23.41%
20.40%
23.48%
33.04%
28.47%
25.52%
27.35%
22.54%
26.09%
29.81%
27.34%
PAT Growth
36.94%
-12.28%
-38.39%
49.19%
44.15%
1.76%
54.24%
-17.30%
-5.81%
32.21%
 
EPS
82.52
60.26
68.70
111.50
74.74
51.85
50.95
33.03
39.94
42.40
32.07

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
13,571.00
12,767.00
11,728.18
9,294.61
7,309.92
6,957.15
5,924.80
5,357.39
4,293.31
3,495.36
Share Capital
53.00
53.00
53.09
53.09
53.09
53.09
53.09
53.09
53.09
26.55
Total Reserves
13,518.00
12,714.00
11,675.09
9,241.52
7,256.83
6,904.06
5,871.71
5,304.30
4,240.21
3,468.81
Non-Current Liabilities
611.00
557.00
436.51
363.94
294.57
991.38
1,768.91
1,411.75
85.17
841.57
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.47
1.05
Long Term Provisions
37.00
31.00
26.71
25.42
20.52
772.54
1,577.26
1,288.92
11.57
714.30
Current Liabilities
1,755.00
1,539.00
2,454.44
1,728.35
1,820.53
846.75
653.42
659.45
519.50
775.53
Trade Payables
824.00
762.00
795.70
763.20
590.72
492.26
411.21
445.80
232.69
226.87
Other Current Liabilities
404.00
332.00
394.02
340.42
290.09
243.59
175.46
176.63
240.58
203.45
Short Term Borrowings
0.00
0.00
0.00
0.35
33.63
105.60
63.11
35.74
41.42
25.07
Short Term Provisions
527.00
445.00
1,264.72
624.38
906.09
5.30
3.64
1.28
4.81
320.14
Total Liabilities
15,937.00
14,863.00
14,619.13
11,386.90
9,425.02
8,795.28
8,347.13
7,428.59
4,897.98
5,112.46
Net Block
4,739.00
4,722.00
4,325.05
3,703.87
2,781.85
2,087.77
1,996.19
1,559.19
1,438.77
1,308.89
Gross Block
6,760.00
6,365.00
5,624.27
4,691.86
3,514.25
2,633.93
2,373.45
1,793.95
2,196.08
1,953.02
Accumulated Depreciation
2,021.00
1,643.00
1,299.22
987.99
732.40
546.16
377.26
234.76
757.32
644.13
Non Current Assets
5,785.00
5,113.00
5,008.74
4,596.30
3,851.49
4,145.23
3,812.01
3,418.08
1,870.93
2,340.06
Capital Work in Progress
778.00
212.00
469.93
710.62
919.69
491.91
119.76
443.57
263.91
218.18
Non Current Investment
82.00
77.00
72.01
0.01
0.01
547.26
0.01
0.01
0.01
0.00
Long Term Loans & Adv.
176.00
97.00
133.70
172.59
144.50
1,012.93
1,688.23
1,406.48
162.44
812.63
Other Non Current Assets
10.00
5.00
8.05
9.21
5.44
5.36
7.82
8.83
5.80
0.35
Current Assets
10,152.00
9,750.00
9,610.39
6,790.60
5,573.53
4,650.05
4,535.12
4,010.51
3,027.04
2,772.40
Current Investments
0.00
0.00
0.00
0.00
971.35
1,398.34
1,889.28
1,630.72
802.85
733.00
Inventories
3,184.00
3,000.00
2,828.62
2,145.23
1,863.86
1,772.34
1,350.67
1,319.91
1,207.83
1,162.64
Sundry Debtors
2,156.00
1,793.00
2,423.88
1,676.52
1,413.35
1,163.37
1,014.36
900.92
880.92
741.64
Cash & Bank
3,980.00
4,214.00
2,818.88
2,156.03
122.63
115.26
112.46
78.70
73.43
65.22
Other Current Assets
832.00
28.00
29.69
51.95
1,202.34
200.74
168.35
80.26
62.01
69.89
Short Term Loans & Adv.
794.00
715.00
1,509.32
760.87
1,150.18
58.54
43.37
59.59
42.88
54.98
Net Current Assets
8,397.00
8,211.00
7,155.95
5,062.25
3,753.00
3,803.30
3,881.70
3,351.06
2,507.54
1,996.87
Total Assets
15,937.00
14,863.00
14,619.13
11,386.90
9,425.02
8,795.28
8,347.13
7,428.59
4,897.97
5,112.46

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
1,261.00
2,459.00
1,911.80
1,946.93
1,215.94
954.30
775.86
1,150.37
1,037.86
826.33
PBT
2,163.00
2,369.00
3,683.50
2,666.04
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
Adjustment
81.00
144.00
239.73
189.29
60.01
83.51
32.19
93.87
60.94
91.24
Changes in Working Capital
-607.00
419.00
-1,370.45
-264.08
-218.30
-499.84
-219.11
-37.14
-155.03
-125.55
Cash after chg. in Working capital
1,637.00
2,932.00
2,552.78
2,591.25
1,661.17
1,438.74
1,044.41
1,452.07
1,298.75
1,037.76
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-376.00
-473.00
-640.98
-644.32
-445.23
-484.44
-268.55
-301.70
-260.89
-211.43
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-269.00
-2,707.00
-2,194.92
75.13
-83.47
-685.40
-478.30
-1,139.60
-406.41
-520.84
Net Fixed Assets
-960.00
-482.38
-691.54
-968.33
-1,302.55
-632.52
-255.54
222.19
-288.75
-286.31
Net Investments
-5.00
-4.63
-72.00
971.35
974.24
-56.30
-257.57
-826.05
-77.22
-231.12
Others
696.00
-2,219.99
-1,431.38
72.11
244.84
3.42
34.81
-535.74
-40.44
-3.41
Cash from Financing Activity
-799.00
-797.00
-532.44
-34.89
-1,091.42
-245.94
-314.16
2.38
-631.12
-302.95
Net Cash Inflow / Outflow
193.00
-1,045.00
-815.56
1,987.17
41.05
22.96
-16.60
13.15
0.33
2.54
Opening Cash & Equivalents
170.00
1,215.00
2,030.32
43.15
2.10
-20.86
-4.26
-17.41
17.62
15.09
Closing Cash & Equivalent
363.00
170.00
1,214.76
2,030.32
43.15
2.10
-20.86
-4.26
17.95
17.62

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
512.11
481.77
441.82
350.15
275.38
262.09
223.20
201.82
161.73
131.67
ROA
10.39%
12.37%
22.77%
19.07%
15.11%
15.78%
11.12%
17.21%
22.49%
18.21%
ROE
12.15%
14.89%
28.16%
23.90%
19.30%
21.00%
15.55%
21.98%
28.91%
26.37%
ROCE
16.46%
19.36%
35.06%
32.07%
25.36%
28.50%
21.68%
28.75%
35.57%
33.06%
Fixed Asset Turnover
1.20
1.30
1.74
1.70
1.77
1.98
1.88
2.06
1.83
1.70
Receivable days
91.33
98.42
83.26
80.66
86.18
80.35
89.33
79.19
77.83
85.12
Inventory Days
143.02
136.04
100.99
104.66
121.62
115.23
124.56
112.34
113.70
121.69
Payable days
92.50
93.12
95.88
106.32
93.73
52.21
60.15
47.14
35.06
33.55
Cash Conversion Cycle
141.85
141.35
88.36
79.00
114.07
143.37
153.75
144.39
156.47
173.26
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.02
0.01
0.01
0.01
0.01
Interest Cover
541.75
1185.50
1842.75
1270.54
255.83
397.38
520.55
416.28
294.75
373.59

News Update:


  • Divi's Laboratories inks pact with global pharma company
    26th May 2025, 12:29 PM

    Under this agreement, the company will be manufacturing and supplying advanced intermediates as per the commercial terms agreed between the parties

    Read More
  • Divi's Laboratories inks supply agreement with global pharmaceuticals firm
    21st Apr 2025, 11:59 AM

    The company expects meaningful revenue contribution from this long-term agreement

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.